Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
1.
Vaccines (Basel) ; 8(3)2020 Jul 22.
Artículo en Inglés | MEDLINE | ID: mdl-32707906

RESUMEN

Human cytomegalovirus (HCMV) infection rates approach 100% by the first year of life in low-income countries. It is not known if this drives changes to innate immunity in early life and thereby altered immune reactivity to infections and vaccines. Given the panoply of sex differences in immunity, it is feasible that any immunological effects of HCMV would differ in males and females. We analysed ex vivo innate cytokine responses to a panel of toll-like receptor (TLR) ligands in 108 nine-month-old Gambian males and females participating in a vaccine trial. We found evidence that HCMV suppressed reactivity to TLR2 and TLR7/8 stimulation in females but not males. This is likely to contribute to sex differences in responses to infections and vaccines in early life and has implications for the development of TLR ligands as vaccine adjuvants. Development of an effective HCMV vaccine would be able to circumvent some of these potentially negative effects of HCMV infection in childhood.

2.
Front Immunol ; 11: 1083, 2020.
Artículo en Inglés | MEDLINE | ID: mdl-32582177

RESUMEN

Human cytomegalovirus (HCMV) infection has a profound effect on the human immune system, causing massive clonal expansion of CD8, and to a lesser extend CD4 T cells. The few human trials that have explored the effect of HCMV infection on responses to vaccination are conflicting, with some studies suggesting no effect whilst others suggest decreased or increased immune responses. Recent studies indicate substantial differences in overall immune system reactivity to vaccines based on age and sex, particularly cellular immunity. 225 nine-month old Gambian infants were immunized with diphtheria-tetanus-whole cell pertussis and/or measles vaccines. HCMV infection status was determined by the presence of CMV DNA by PCR of urine samples prior to vaccination. The effect of HCMV infection on either protective antibody immunity or vaccine-specific and overall cellular immune responses 4 weeks post-vaccination was determined, further stratified by sex. Tetanus toxoid-specific antibody responses were significantly lower in HCMV+ infants compared to their HCMV- counterparts, while pertussis, diphtheria and measles antibody responses were generally comparable between the groups. Responses to general T cell stimulation with anti-CD3/anti-CD28 as well as antigen-specific cytokine responses to purified protein derivative (PPD) were broadly suppressed in infants infected with HCMV but, perhaps surprisingly, there was only a minimal impact on antigen-specific cellular responses to vaccine antigens. There was evidence for subtle sex differences in the effects of HCMV infection, in keeping with the emerging evidence suggesting sex differences in homeostatic immunity and in responses to vaccines. This study reassuringly suggests that the high rates of HCMV infection in low income settings have little clinically significant impact on antibody and cellular responses to early life vaccines, while confirming the importance of sex stratification in such studies.


Asunto(s)
Infecciones por Citomegalovirus/inmunología , Vacuna contra Difteria, Tétanos y Tos Ferina/inmunología , Vacuna Antisarampión/inmunología , Anticuerpos Antibacterianos/biosíntesis , Anticuerpos Antivirales/biosíntesis , Estudios de Cohortes , Citocinas/sangre , Femenino , Gambia , Humanos , Tolerancia Inmunológica , Inmunidad Celular , Inmunoglobulina G/sangre , Lactante , Masculino , Estudios Prospectivos , Caracteres Sexuales , Linfocitos T/inmunología , Toxoide Tetánico/inmunología
3.
Front Immunol ; 8: 921, 2017.
Artículo en Inglés | MEDLINE | ID: mdl-28855899

RESUMEN

Regulatory T cells (Tregs) play a key homeostatic role by suppressing immune responses. They have been targeted in mouse and human cancer studies to improve vaccine immunogenicity and tumor clearance. A number of commercially available drugs and experimental vaccine adjuvants have been shown to target Tregs. Infants have high numbers of Tregs and often have poor responses to vaccination, yet the role Tregs play in controlling vaccine immunogenicity has not been explored in this age group. Herein, we explore the role of CD4+FOXP3+CD127- Tregs in controlling immunity in infant males and females to vaccination with diphtheria-tetanus-whole cell pertussis (DTP) and/or measles vaccine (MV). We find correlative evidence that circulating Tregs at the time of vaccination suppress antibody responses to MV but not DTP; and Tregs 4 weeks after DTP vaccination may suppress vaccine-specific cellular immunity. This opens the exciting possibility that Tregs may provide a future target for improved vaccine responses in early life, including reducing the number of doses of vaccine required. Such an approach would need to be safe and the benefits outweigh the risks, thus further research in this area is required.

4.
Clin Infect Dis ; 63(9): 1213-1226, 2016 11 01.
Artículo en Inglés | MEDLINE | ID: mdl-27436422

RESUMEN

Vaccines can have nontargeted heterologous effects that manifest as increased protection against nonvaccine infections, as described for measles vaccine (MV), or increased susceptibility to infections and death, as described following diphtheria-tetanus-whole cell pertussis (DTP) vaccination. The mechanisms are unknown, and high-quality immunological studies are lacking. This study was designed to investigate the heterologous effects of MV and DTP in 302 Gambian infants. The results support a sex-differential immunosuppressive effect of DTP on innate proinflammatory responses and T-cell immunity. Males but not females receiving MV had enhanced proinflammatory innate responses. The results point to modified signaling via Toll-like receptor 4 (TLR4) as a possible mechanism for the effects on innate immunity. When both vaccines were administered together, purified protein derivative responses were enhanced in females but downregulated in males. Collectively, these data indicate immunological effects that could account for heterologous effects of MV and DTP, to take forward into prospective trials.


Asunto(s)
Vacuna contra Difteria, Tétanos y Tos Ferina/inmunología , Vacuna Antisarampión/inmunología , Caracteres Sexuales , Anticuerpos Antivirales/sangre , Estudios de Cohortes , Citocinas/sangre , Femenino , Gambia , Genoma Humano , Humanos , Inmunidad Innata , Inmunoglobulina G/sangre , Terapia de Inmunosupresión , Lactante , Estudios Longitudinales , Masculino , ARN , Linfocitos T/inmunología , Receptor Toll-Like 4/agonistas , Receptor Toll-Like 4/metabolismo , Transcriptoma
5.
Eur J Immunol ; 40(4): 1062-72, 2010 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-20039298

RESUMEN

Placental malaria (PM), a frequent infection of pregnancy, provides an ideal opportunity to investigate the impact on immune development of exposure of the foetal immune system to foreign Ag. We investigated the effect of PM on the regulatory phenotype and function of cord blood cells from healthy Gambian newborns and peripheral blood cells from their mothers, and analyzed for effects on the balance between regulatory and effector responses. Using the gold standard for classifying PM we further distinguished between resolved infection and acute or chronic PM active at the time of delivery. We show that exposure to malarial Ag in utero results in the expansion of malaria-specific FOXP3(+) Treg and more generalized FOXP3(+) CD4(+) Treg in chronic and resolved PM, alongside increased Th1 pro-inflammatory responses (IFN-gamma, TNF-alpha, IFN-gamma:IL-10) in resolved PM infection only. These observations demonstrate a clear effect of exposure to malarial Ag in foetal life on the immune environment at birth, with a regulatory response dominating in the newborns with ongoing chronic PM, while those with resolved infection produce both regulatory and inflammatory responses. The findings might explain some of the adverse effects on the health of babies born to women with PM.


Asunto(s)
Linfocitos T CD4-Positivos/inmunología , Sangre Fetal/inmunología , Enfermedades Fetales/inmunología , Feto/inmunología , Recién Nacido/inmunología , Transmisión Vertical de Enfermedad Infecciosa , Malaria Falciparum/inmunología , Parasitemia/inmunología , Enfermedades Placentarias/inmunología , Complicaciones Infecciosas del Embarazo/inmunología , Subgrupos de Linfocitos T/inmunología , Adulto , Animales , Linfocitos T CD4-Positivos/química , Linfocitos T CD4-Positivos/metabolismo , Femenino , Sangre Fetal/parasitología , Enfermedades Fetales/parasitología , Factores de Transcripción Forkhead/análisis , Humanos , Recién Nacido/sangre , Interferón gamma/metabolismo , Interleucina-10/metabolismo , Malaria Falciparum/congénito , Malaria Falciparum/embriología , Masculino , Parasitemia/congénito , Parasitemia/embriología , Enfermedades Placentarias/parasitología , Embarazo , Complicaciones Infecciosas del Embarazo/parasitología , Subgrupos de Linfocitos T/química , Subgrupos de Linfocitos T/metabolismo , Factor de Crecimiento Transformador beta/metabolismo , Factor de Necrosis Tumoral alfa/metabolismo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...